PharmGen Science Inc
KRX:004720
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PharmGen Science Inc
KRX:004720
|
KR |
Balance Sheet
Balance Sheet Decomposition
PharmGen Science Inc
PharmGen Science Inc
Balance Sheet
PharmGen Science Inc
| Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||||
| Cash & Cash Equivalents |
1 151
|
3 038
|
4 307
|
1 576
|
1 250
|
622
|
520
|
2 179
|
6 026
|
813
|
2 557
|
3 571
|
5 431
|
5 181
|
22 412
|
11 394
|
25 917
|
33 656
|
19 355
|
36 906
|
37 916
|
|
| Cash Equivalents |
1 151
|
3 038
|
4 307
|
1 576
|
1 250
|
622
|
520
|
2 179
|
6 026
|
813
|
2 557
|
3 571
|
5 431
|
5 181
|
22 412
|
11 394
|
25 917
|
33 656
|
19 355
|
36 906
|
37 916
|
|
| Short-Term Investments |
1 203
|
1 618
|
1 293
|
7 053
|
4 666
|
2 134
|
1 993
|
564
|
75
|
45
|
2 004
|
5 090
|
17 000
|
16 000
|
23 000
|
4 000
|
4 531
|
531
|
531
|
532
|
0
|
|
| Total Receivables |
19 256
|
23 546
|
28 031
|
31 333
|
38 607
|
31 172
|
24 541
|
22 212
|
20 336
|
20 261
|
17 794
|
19 370
|
16 696
|
20 232
|
20 134
|
19 772
|
24 020
|
20 166
|
28 638
|
36 414
|
39 662
|
|
| Accounts Receivables |
17 614
|
21 356
|
25 395
|
29 336
|
36 505
|
25 439
|
22 694
|
18 749
|
18 407
|
19 184
|
16 997
|
18 879
|
16 246
|
19 654
|
19 400
|
19 386
|
21 404
|
19 857
|
28 037
|
35 617
|
39 299
|
|
| Other Receivables |
1 642
|
2 190
|
2 636
|
1 997
|
2 102
|
5 733
|
1 847
|
3 463
|
1 929
|
1 077
|
797
|
491
|
450
|
578
|
734
|
386
|
2 616
|
309
|
600
|
797
|
362
|
|
| Inventory |
5 522
|
5 978
|
9 411
|
12 179
|
8 963
|
7 273
|
9 319
|
6 024
|
5 712
|
7 792
|
9 990
|
8 721
|
12 835
|
11 934
|
12 002
|
13 780
|
16 420
|
15 225
|
20 900
|
20 713
|
31 845
|
|
| Other Current Assets |
356
|
1 109
|
951
|
1 965
|
1 286
|
1 346
|
330
|
572
|
298
|
1 769
|
1 450
|
1 444
|
1 125
|
1 975
|
3 406
|
1 668
|
4 013
|
7 801
|
1 117
|
762
|
1 286
|
|
| Total Current Assets |
27 487
|
35 288
|
43 994
|
54 106
|
54 771
|
42 548
|
36 703
|
31 550
|
32 447
|
30 680
|
33 795
|
38 196
|
53 087
|
55 322
|
80 955
|
50 615
|
74 901
|
77 379
|
70 541
|
95 327
|
110 709
|
|
| PP&E Net |
3 078
|
3 501
|
4 429
|
7 437
|
7 542
|
3 864
|
7 692
|
7 322
|
7 125
|
6 415
|
5 939
|
5 950
|
8 348
|
8 839
|
8 618
|
15 595
|
17 214
|
34 902
|
42 444
|
41 273
|
38 863
|
|
| PP&E Gross |
3 078
|
3 501
|
4 429
|
7 437
|
7 542
|
3 864
|
7 692
|
7 322
|
7 125
|
6 415
|
5 939
|
5 950
|
8 348
|
8 839
|
8 618
|
15 595
|
17 214
|
34 902
|
42 444
|
41 273
|
38 863
|
|
| Accumulated Depreciation |
5 202
|
4 837
|
4 525
|
5 409
|
6 768
|
7 341
|
7 407
|
8 242
|
8 499
|
9 372
|
9 960
|
10 705
|
11 356
|
12 378
|
13 372
|
15 285
|
17 787
|
19 406
|
16 831
|
18 615
|
21 322
|
|
| Intangible Assets |
197
|
324
|
311
|
266
|
306
|
413
|
655
|
522
|
907
|
784
|
680
|
636
|
914
|
995
|
1 051
|
992
|
1 936
|
4 434
|
6 178
|
6 418
|
7 133
|
|
| Goodwill |
16 238
|
12 621
|
9 004
|
5 388
|
1 795
|
0
|
0
|
0
|
54
|
54
|
54
|
54
|
54
|
54
|
54
|
54
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
884
|
870
|
872
|
617
|
0
|
728
|
725
|
784
|
532
|
857
|
477
|
442
|
409
|
|
| Long-Term Investments |
132
|
11 026
|
18 702
|
15 459
|
22 291
|
11 033
|
9 910
|
2 716
|
822
|
515
|
693
|
986
|
1 305
|
2 531
|
3 585
|
26 095
|
37 707
|
102 746
|
197 748
|
192 446
|
206 303
|
|
| Other Long-Term Assets |
2 354
|
3 707
|
2 359
|
1 831
|
1 948
|
1 066
|
773
|
714
|
375
|
11
|
11
|
11
|
593
|
11
|
3 206
|
5 901
|
3 253
|
5
|
4
|
11
|
33
|
|
| Other Assets |
16 238
|
12 621
|
9 004
|
5 388
|
1 795
|
0
|
0
|
0
|
54
|
54
|
54
|
54
|
54
|
54
|
54
|
54
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
49 485
N/A
|
66 467
+34%
|
78 800
+19%
|
84 487
+7%
|
88 653
+5%
|
58 924
-34%
|
55 734
-5%
|
42 824
-23%
|
42 614
0%
|
39 329
-8%
|
42 043
+7%
|
46 450
+10%
|
64 300
+38%
|
68 480
+7%
|
98 193
+43%
|
100 035
+2%
|
135 544
+35%
|
220 324
+63%
|
317 391
+44%
|
335 917
+6%
|
363 450
+8%
|
|
| Liabilities | ||||||||||||||||||||||
| Accounts Payable |
10 104
|
8 265
|
10 262
|
5 803
|
6 436
|
2 934
|
2 244
|
681
|
1 928
|
2 618
|
4 161
|
3 067
|
3 996
|
3 954
|
1 869
|
4 082
|
4 480
|
4 505
|
4 938
|
4 868
|
6 621
|
|
| Accrued Liabilities |
540
|
1 033
|
1 227
|
643
|
1 495
|
1 458
|
581
|
624
|
432
|
307
|
255
|
629
|
1 082
|
2 168
|
3 211
|
2 488
|
3 576
|
4 296
|
7 228
|
8 059
|
7 822
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
76
|
0
|
0
|
0
|
0
|
1 169
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
8 404
|
13 689
|
15 980
|
28 658
|
31 674
|
18 229
|
19 682
|
12 670
|
6 779
|
4 650
|
9 064
|
4 143
|
10 000
|
0
|
19 125
|
18 352
|
20 388
|
46 262
|
39 001
|
37 431
|
38 640
|
|
| Other Current Liabilities |
3 201
|
3 493
|
3 410
|
4 519
|
12 115
|
7 286
|
6 617
|
7 702
|
4 555
|
4 478
|
4 200
|
4 966
|
6 699
|
3 964
|
8 763
|
5 418
|
9 243
|
14 890
|
17 017
|
12 814
|
12 339
|
|
| Total Current Liabilities |
22 249
|
26 480
|
30 879
|
39 624
|
51 720
|
29 908
|
29 123
|
21 677
|
13 695
|
12 053
|
17 681
|
12 805
|
21 853
|
10 086
|
32 968
|
30 340
|
37 688
|
71 122
|
68 185
|
63 172
|
65 422
|
|
| Long-Term Debt |
976
|
5 069
|
9 684
|
597
|
457
|
316
|
228
|
96
|
54
|
236
|
234
|
233
|
231
|
229
|
206
|
1 427
|
1 017
|
578
|
490
|
532
|
350
|
|
| Deferred Income Tax |
25
|
0
|
0
|
0
|
19
|
0
|
61
|
628
|
628
|
628
|
628
|
628
|
628
|
628
|
0
|
0
|
0
|
7 770
|
28 187
|
29 021
|
31 178
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
76
|
99
|
46
|
34
|
71
|
55
|
37
|
76
|
104
|
142
|
44
|
8
|
9
|
10
|
11
|
|
| Other Liabilities |
1 326
|
1 848
|
1 615
|
1 785
|
1 646
|
1 649
|
1 497
|
1 731
|
2 333
|
2 578
|
3 384
|
4 126
|
5 180
|
6 484
|
8 173
|
12 021
|
13 269
|
13 923
|
13 414
|
14 981
|
17 072
|
|
| Total Liabilities |
24 575
N/A
|
33 397
+36%
|
42 177
+26%
|
42 006
0%
|
53 841
+28%
|
31 873
-41%
|
30 834
-3%
|
24 034
-22%
|
16 756
-30%
|
15 460
-8%
|
21 856
+41%
|
17 736
-19%
|
27 856
+57%
|
17 502
-37%
|
41 450
+137%
|
43 931
+6%
|
52 018
+18%
|
93 384
+80%
|
110 267
+18%
|
107 696
-2%
|
114 011
+6%
|
|
| Equity | ||||||||||||||||||||||
| Common Stock |
32 150
|
34 068
|
34 068
|
36 172
|
36 240
|
29 247
|
29 247
|
31 788
|
38 600
|
39 737
|
4 074
|
4 714
|
5 028
|
5 644
|
5 785
|
5 843
|
7 356
|
7 617
|
7 915
|
9 001
|
9 101
|
|
| Retained Earnings |
7 281
|
4 921
|
889
|
668
|
10 648
|
5 187
|
4 153
|
12 805
|
18 240
|
21 630
|
26 616
|
1 686
|
4 965
|
8 897
|
12 278
|
10 691
|
20 282
|
52 972
|
125 089
|
130 093
|
135 699
|
|
| Additional Paid In Capital |
0
|
3 270
|
1 482
|
7 590
|
8 980
|
3 824
|
637
|
620
|
6 324
|
6 588
|
43 584
|
23 170
|
27 306
|
37 285
|
39 529
|
41 243
|
59 229
|
65 502
|
69 897
|
81 599
|
82 597
|
|
| Unrealized Security Profit/Loss |
40
|
653
|
183
|
965
|
1 223
|
2
|
1
|
19
|
5
|
5
|
6
|
7
|
5
|
0
|
0
|
825
|
2 493
|
1 698
|
5 072
|
8 134
|
22 793
|
|
| Treasury Stock |
0
|
0
|
0
|
983
|
983
|
570
|
570
|
570
|
570
|
570
|
587
|
587
|
587
|
587
|
587
|
587
|
587
|
587
|
587
|
587
|
587
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
261
|
263
|
261
|
261
|
261
|
261
|
261
|
261
|
261
|
261
|
261
|
261
|
261
|
261
|
18
|
163
|
|
| Total Equity |
24 910
N/A
|
33 070
+33%
|
36 623
+11%
|
42 481
+16%
|
34 812
-18%
|
27 052
-22%
|
24 899
-8%
|
18 790
-25%
|
25 858
+38%
|
23 869
-8%
|
20 187
-15%
|
28 714
+42%
|
36 445
+27%
|
50 978
+40%
|
56 743
+11%
|
56 104
-1%
|
83 526
+49%
|
126 940
+52%
|
207 125
+63%
|
228 221
+10%
|
249 439
+9%
|
|
| Total Liabilities & Equity |
49 485
N/A
|
66 467
+34%
|
78 800
+19%
|
84 487
+7%
|
88 653
+5%
|
58 924
-34%
|
55 734
-5%
|
42 824
-23%
|
42 614
0%
|
39 329
-8%
|
42 043
+7%
|
46 450
+10%
|
64 300
+38%
|
68 480
+7%
|
98 193
+43%
|
100 035
+2%
|
135 544
+35%
|
220 324
+63%
|
317 391
+44%
|
335 917
+6%
|
363 450
+8%
|
|
| Shares Outstanding | ||||||||||||||||||||||
| Common Shares Outstanding |
4
|
4
|
4
|
5
|
5
|
6
|
6
|
7
|
8
|
8
|
8
|
9
|
10
|
11
|
12
|
12
|
15
|
15
|
16
|
18
|
18
|
|